Keyphrases
Alzheimer's Disease
100%
Behavioral Effects
100%
Multi-target
100%
Anticholinesterasic
100%
Acetylcholinesterase Inhibitors (AChEI)
60%
Huprine
60%
Disease-modifying Therapy
40%
Acetylcholinesterase
40%
Neuropsychiatric Symptoms of Dementia
40%
Alzheimer's Disease Model
20%
Cognitive Deficits
20%
Middle-aged
20%
Age-related Illnesses
20%
Potential Gains
20%
Mouse Model
20%
Neuropathology
20%
Binding Site
20%
Anxiety-like Behavior
20%
Amyloidogenic
20%
Disease-related
20%
Pharmacophore
20%
Neurotransmission
20%
Amyloid Aggregation
20%
Alzheimer's Disease Treatment
20%
Neuroinflammation
20%
Symptomatology
20%
Clinical Symptoms
20%
Tacrine
20%
Amyloid Burden
20%
Pharmacological Profile
20%
Pharmacophoric
20%
Molecular Hybridization
20%
Pharmacological Approaches
20%
AChE Inhibitors
20%
Behavioral Correlates
20%
Levetiracetam
20%
Research Consortium
20%
Epileptiform Activity
20%
Inhibitory Action
20%
Huprine X
20%
Huperzine A
20%
Donepezil
20%
Temporal Frames
20%
Hybrid Molecules
20%
Spontaneous Seizures
20%
Disease-modifying Effect
20%
Medicine and Dentistry
Behavioral Effect
100%
Alzheimer's Disease
100%
Diseases
66%
Acetylcholinesterase Inhibitor
50%
Acetylcholinesterase
50%
In Vitro
33%
Amyloid Protein
33%
Ex Vivo
16%
Cognitive Defect
16%
Tacrine
16%
middle age
16%
Neuroinflammation
16%
Combination Therapy
16%
Symptomatology
16%
Side Effect
16%
Synaptic Transmission
16%
Levetiracetam
16%
Epileptiform Activity
16%
Heterodimer
16%
Donepezil
16%
Huperzine A
16%
Treatment of Alzheimer's Disease
16%
Molecular Hybridization
16%
Neuropathology
16%
Pharmacophore
16%
Epileptic Seizure
16%
Binding Site
16%
Pharmacology, Toxicology and Pharmaceutical Science
Behavioral Effect
100%
Alzheimer's Disease
100%
Disease
57%
Acetylcholinesterase
42%
Cholinesterase Inhibitor
42%
Amyloid Protein
28%
Mouse Model
14%
Symptomatology
14%
Binding Site
14%
Cognitive Defect
14%
Combination Therapy
14%
Nervous System Inflammation
14%
Side Effect
14%
Heterodimer
14%
Tacrine
14%
Levetiracetam
14%
Huperzine A
14%
Donepezil
14%
Neuroscience
Behavioral Effect
100%
Alzheimer's Disease
100%
Acetylcholinesterase Inhibitor
50%
Acetylcholinesterase
50%
In Vitro
33%
Amyloid Protein
33%
In Vivo
16%
Tacrine
16%
Cognitive Disorders
16%
Levetiracetam
16%
Treatment of Alzheimer's Disease
16%
Binding Site
16%
Huperzine A
16%
Behavior (Neuroscience)
16%
Synaptic Transmission
16%
Donepezil
16%